Carbazeran
CAS No. 70724-25-3
Carbazeran( UK 31557 | UK-31557 | UK31557 | UK 31,557 | UK-31,557 | UK31,557 | )
Catalog No. M27410 CAS No. 70724-25-3
Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 56 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 179 | In Stock |
|
| 50MG | 265 | In Stock |
|
| 100MG | 398 | In Stock |
|
| 200MG | 615 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCarbazeran
-
NoteResearch use only, not for human use.
-
Brief DescriptionCarbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
-
DescriptionCarbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
-
In Vitro——
-
In Vivo——
-
SynonymsUK 31557 | UK-31557 | UK31557 | UK 31,557 | UK-31,557 | UK31,557 |
-
PathwayAngiogenesis
-
TargetPDE
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number70724-25-3
-
Formula Weight360.414
-
Molecular FormulaC18H24N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 125 mg/mL (346.83 mM)
-
SMILESCCNC(=O)OC1CCN(CC1)c1nncc2cc(OC)c(OC)cc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jean-Louis H. Dasseux, et al. Ketone compounds and compositions for cholesterol management and related uses. WO2002030860A2.
molnova catalog
related products
-
Heptaminol hydrochlo...
Heptaminol hydrochloride is a vasoconstrictor, used in the treatment of low blood pressure, particularly orthostatic hypotension.
-
MK-0873
MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
-
CRT0273750
CRT0273750 regulates plasma LPA levels and is suitable for in vivo studies. CRT0273750 is an autotaxin (ATX) inhibitor with IC50 of 0.014 μM.
Cart
sales@molnova.com